- Home
- VITL vs TARS Comparison
VITL vs TARS Comparison
Compare VITL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- TARS
- Stock Information
- Founded
- VITL 2007
- TARS 2016
- Country
- VITL United States
- TARS United States
- Employees
- VITL N/A
- TARS N/A
- Industry
- VITL Packaged Foods
- TARS Medicinal Chemicals and Botanical Products
- Sector
- VITL Consumer Staples
- TARS Health Care
- Exchange
- VITL Nasdaq
- TARS Nasdaq
- Market Cap
- VITL 1.6B
- TARS 1.7B
- IPO Year
- VITL 2020
- TARS 2020
- Fundamental
- Price
- VITL $39.54
- TARS $40.45
- Analyst Decision
- VITL Strong Buy
- TARS Strong Buy
- Analyst Count
- VITL 8
- TARS 7
- Target Price
- VITL $43.88
- TARS $67.14
- AVG Volume (30 Days)
- VITL 828.7K
- TARS 625.5K
- Earning Date
- VITL 08-07-2025
- TARS 08-07-2025
- Dividend Yield
- VITL N/A
- TARS N/A
- EPS Growth
- VITL 30.46
- TARS N/A
- EPS
- VITL 1.13
- TARS N/A
- Revenue
- VITL $620,567,000.00
- TARS $233,674,000.00
- Revenue This Year
- VITL $25.26
- TARS $122.94
- Revenue Next Year
- VITL $19.41
- TARS $44.14
- P/E Ratio
- VITL $35.15
- TARS N/A
- Revenue Growth
- VITL 23.96
- TARS 449.03
- 52 Week Low
- VITL $27.91
- TARS $20.08
- 52 Week High
- VITL $46.58
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- VITL 74.69
- TARS 42.33
- Support Level
- VITL $35.30
- TARS $39.19
- Resistance Level
- VITL $39.66
- TARS $41.50
- Average True Range (ATR)
- VITL 1.58
- TARS 1.56
- MACD
- VITL 0.61
- TARS 0.11
- Stochastic Oscillator
- VITL 98.62
- TARS 44.68
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.